I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 26% ± 11% | |
| oligodendrocyte | 11 studies | 28% ± 10% | |
| oligodendrocyte precursor cell | 9 studies | 26% ± 13% | |
| astrocyte | 9 studies | 28% ± 12% | |
| type I pneumocyte | 7 studies | 25% ± 8% | |
| microglial cell | 7 studies | 25% ± 7% | |
| epithelial cell | 7 studies | 37% ± 20% | |
| ciliated cell | 7 studies | 27% ± 10% | |
| GABAergic neuron | 7 studies | 37% ± 20% | |
| glutamatergic neuron | 6 studies | 45% ± 25% | |
| interneuron | 6 studies | 35% ± 21% | |
| adipocyte | 6 studies | 22% ± 3% | |
| fibroblast | 6 studies | 24% ± 9% | |
| type II pneumocyte | 6 studies | 20% ± 5% | |
| macrophage | 6 studies | 28% ± 9% | |
| natural killer cell | 5 studies | 17% ± 1% | |
| classical monocyte | 5 studies | 19% ± 4% | |
| neuron | 5 studies | 27% ± 12% | |
| retinal rod cell | 5 studies | 22% ± 5% | |
| goblet cell | 5 studies | 31% ± 27% | |
| club cell | 5 studies | 21% ± 6% | |
| B cell | 4 studies | 18% ± 1% | |
| myeloid cell | 4 studies | 21% ± 2% | |
| lymphocyte | 4 studies | 25% ± 7% | |
| basal cell | 4 studies | 34% ± 17% | |
| monocyte | 4 studies | 21% ± 2% | |
| T cell | 4 studies | 17% ± 1% | |
| endothelial cell of lymphatic vessel | 4 studies | 27% ± 9% | |
| pericyte | 4 studies | 23% ± 10% | |
| smooth muscle cell | 4 studies | 19% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 2% | |
| hematopoietic precursor cell | 3 studies | 20% ± 4% | |
| granule cell | 3 studies | 18% ± 4% | |
| retinal ganglion cell | 3 studies | 21% ± 3% | |
| plasma cell | 3 studies | 25% ± 6% | |
| squamous epithelial cell | 3 studies | 37% ± 23% | |
| retinal cone cell | 3 studies | 23% ± 5% | |
| respiratory goblet cell | 3 studies | 23% ± 7% | |
| hepatocyte | 3 studies | 33% ± 18% | |
| dendritic cell | 3 studies | 24% ± 8% |
